{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "Liu_et_al.__2024_",
  "verification_stats": {
    "total_extracted": 6,
    "verified": 4,
    "rejected": 2,
    "verification_rate": 0.6666666666666666
  },
  "verified_evidence": [
    {
      "id": 1,
      "quote": "The manufacturing process can lead to egg adapted mutations in the hemagglutinin (HA) protein in IIV, that could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.",
      "supports_claim": true,
      "explanation": "The quote appears in the first paragraph of the document, though with some minor OCR artifacts: 'manufacturing process can lead to egg adapted mutations in themagglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i'. Despite the artifacts, the semantic content matches the provided quote: the manufacturing process can lead to egg-adapted mutations in the HA protein in inactivated influenza vaccine (IIV), which could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.. The quote directly supports the claim. It explicitly states that the manufacturing process (specifically for egg-based vaccines) can lead to egg-adapted mutations in the hemagglutinin (HA) protein, which could result in altered antigenicity and reduced vaccine effectiveness. This matches the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness. The quote does not mention cell-based vaccines developing mutations, but it does substantiate the risk for egg-based vaccines as described in the claim.",
      "presence_explanation": "The quote appears in the first paragraph of the document, though with some minor OCR artifacts: 'manufacturing process can lead to egg adapted mutations in themagglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i'. Despite the artifacts, the semantic content matches the provided quote: the manufacturing process can lead to egg-adapted mutations in the HA protein in inactivated influenza vaccine (IIV), which could result in altered antigenicity and reduced vaccine effectiveness (VE) in the population.",
      "support_explanation": "The quote directly supports the claim. It explicitly states that the manufacturing process (specifically for egg-based vaccines) can lead to egg-adapted mutations in the hemagglutinin (HA) protein, which could result in altered antigenicity and reduced vaccine effectiveness. This matches the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness. The quote does not mention cell-based vaccines developing mutations, but it does substantiate the risk for egg-based vaccines as described in the claim.",
      "original_relevance": "This quote directly states that the manufacturing process for egg-based vaccines can cause mutations in the HA protein, which may change the antigenic properties of the vaccine and reduce its effectiveness, supporting the claim."
    },
    {
      "id": 2,
      "quote": "Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.",
      "supports_claim": true,
      "explanation": "The quote 'Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.' appears in the document, specifically in the author list and summary section on page 1. The wording and meaning are preserved, with only minor formatting differences (e.g., 'immunogenicity' instead of 'immunogen i city', 'epitopes' instead of 'epi to pes'). The factual content is identical.. The quote directly supports the claim. It states that repeat vaccination with egg-based influenza vaccines can preferentially boost antibodies to egg-adapted (mutated) epitopes, which are not present on circulating viruses, and this can reduce immunogenicity (immune response) to the actual circulating viruses. This aligns with the claim that cell- and egg-based flu vaccines can develop mutations during production that may reduce their effectiveness.",
      "presence_explanation": "The quote 'Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epitopes and reduce immunogenicity to circulating viruses.' appears in the document, specifically in the author list and summary section on page 1. The wording and meaning are preserved, with only minor formatting differences (e.g., 'immunogenicity' instead of 'immunogen i city', 'epitopes' instead of 'epi to pes'). The factual content is identical.",
      "support_explanation": "The quote directly supports the claim. It states that repeat vaccination with egg-based influenza vaccines can preferentially boost antibodies to egg-adapted (mutated) epitopes, which are not present on circulating viruses, and this can reduce immunogenicity (immune response) to the actual circulating viruses. This aligns with the claim that cell- and egg-based flu vaccines can develop mutations during production that may reduce their effectiveness.",
      "original_relevance": "This quote explains that repeated use of egg-based vaccines can enhance immune responses to egg-adapted (mutated) epitopes rather than those found on circulating viruses, potentially reducing the vaccine's effectiveness."
    },
    {
      "id": 4,
      "quote": "Several studies have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigenicity and influence immune response.",
      "supports_claim": true,
      "explanation": "The quote appears on page 9 of the document: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' The wording is nearly identical to the quote to verify, with only minor formatting differences (e.g., 'antigen i city' instead of 'antigenicity'). The factual content is preserved.. The quote directly supports the claim. It provides a specific example (Q223R mutation) that arises during egg-based production of the A (H1N1)pdm09 virus, and explicitly states that this mutation can alter antigenicity and influence immune response. This demonstrates that mutations can occur during production and may reduce vaccine effectiveness, thus supporting the claim.",
      "presence_explanation": "The quote appears on page 9 of the document: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' The wording is nearly identical to the quote to verify, with only minor formatting differences (e.g., 'antigen i city' instead of 'antigenicity'). The factual content is preserved.",
      "support_explanation": "The quote directly supports the claim. It provides a specific example (Q223R mutation) that arises during egg-based production of the A (H1N1)pdm09 virus, and explicitly states that this mutation can alter antigenicity and influence immune response. This demonstrates that mutations can occur during production and may reduce vaccine effectiveness, thus supporting the claim.",
      "original_relevance": "This quote provides a specific example of a mutation (Q223R) that occurs during egg-based production, which alters the antigenic properties of the virus and can affect the immune response, supporting the claim."
    },
    {
      "id": "comp_2",
      "quote": "Several studies have reported that Q223R egg adapted change at the HA head domain of A (H1N1) pdm09 virus can promote virus replication in eggs, alter antigenicity and influence immune response 37 42.",
      "supports_claim": true,
      "explanation": "The quote appears on page 9 of the document as: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' This matches the factual content of the quote to verify, with only minor formatting differences (e.g., 'Q223R' vs 'Q223 R', 'antigenicity' vs 'antigen i city'). The meaning and technical content are preserved.. The quote directly states that the Q223R egg-adapted change (a mutation) at the HA head domain of A(H1N1)pdm09 virus can arise during egg-based vaccine production, and that it can alter antigenicity and influence immune response. This supports the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness, since changes in antigenicity and immune response are mechanisms by which effectiveness can be reduced.",
      "presence_explanation": "The quote appears on page 9 of the document as: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' This matches the factual content of the quote to verify, with only minor formatting differences (e.g., 'Q223R' vs 'Q223 R', 'antigenicity' vs 'antigen i city'). The meaning and technical content are preserved.",
      "support_explanation": "The quote directly states that the Q223R egg-adapted change (a mutation) at the HA head domain of A(H1N1)pdm09 virus can arise during egg-based vaccine production, and that it can alter antigenicity and influence immune response. This supports the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness, since changes in antigenicity and immune response are mechanisms by which effectiveness can be reduced.",
      "original_relevance": "This quote provides evidence from multiple studies that specific mutations (such as Q223R) can arise during egg-based vaccine production, affecting antigenicity and immune response, which supports the claim about mutation-induced reduced effectiveness."
    }
  ],
  "rejected_evidence": [
    {
      "id": 3,
      "quote": "Egg adaptation can introduce mutations in the HA protein that are not present in circulating viruses, potentially leading to a mismatch between vaccine-induced immunity and the actual circulating strains.",
      "reason": "not found",
      "original_explanation": "This statement highlights that mutations arising during egg-based vaccine production can cause a mismatch between the vaccine and circulating viruses, which may lower vaccine effectiveness."
    },
    {
      "id": "comp_1",
      "quote": "Egg adaptation can introduce amino acid changes in the HA protein that are not present in the circulating viruses, potentially leading to a mismatch between vaccine-induced immunity and the actual circulating strains.",
      "reason": "not found",
      "original_explanation": "This quote directly states that egg adaptation during vaccine production can cause mutations in the HA protein, which may result in reduced effectiveness due to a mismatch with circulating viruses."
    }
  ],
  "model_used": "gpt-4.1"
}